Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
Latest reported NRIX revenue for 2026-05-31 was $15.3M. Net income was -$176.7M. NRIX currently screens at market cap $1.77B.
Use this NRIX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the NRIX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the NRIX SEC filings page. Lician reads the product cache first so this HTML stays unique to Nurix Therapeutics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full NRIX income, balance, and cash tables.